BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu C, Zhao L, Li L. Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases. Stem Cell Res Ther. 2019;10:199. [PMID: 31287024 DOI: 10.1186/s13287-019-1310-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Wu Z, Yang Q, Ma H. Study the Mechanism of Gualou Niubang Decoction in Treating Plasma Cell Mastitis Based on Network Pharmacology and Molecular Docking. Biomed Res Int 2022;2022:5780936. [PMID: 35757473 DOI: 10.1155/2022/5780936] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jahnavi S, Garg V, Vasandan AB, SundarRaj S, Kumar A, Prasanna S J. Lineage reprogramming of human adipose mesenchymal stem cells to immune modulatory i-Heps. Int J Biochem Cell Biol 2022;149:106256. [PMID: 35772664 DOI: 10.1016/j.biocel.2022.106256] [Reference Citation Analysis]
3 Bogliotti Y, Vander Roest M, Mattis AN, Gish RG, Peltz G, Anwyl R, Kivlighn S, Schuur ER. Clinical Application of Induced Hepatocyte-like Cells Produced from Mesenchymal Stromal Cells: A Literature Review. Cells 2022;11:1998. [DOI: 10.3390/cells11131998] [Reference Citation Analysis]
4 Hernandez JC, Yeh DW, Marh J, Choi HY, Kim J, Chopra S, Ding L, Thornton M, Grubbs B, Makowka L, Sher L, Machida K. Activated and nonactivated MSCs increase survival in humanized mice after acute liver injury through alcohol binging. Hepatol Commun 2022. [PMID: 35246968 DOI: 10.1002/hep4.1924] [Reference Citation Analysis]
5 Ezquer F, Huang YL, Ezquer M. New Perspectives to Improve Mesenchymal Stem Cell Therapies for Drug-Induced Liver Injury. Int J Mol Sci 2022;23:2669. [PMID: 35269830 DOI: 10.3390/ijms23052669] [Reference Citation Analysis]
6 Mikłosz A, Łukaszuk B, Supruniuk E, Grubczak K, Moniuszko M, Choromańska B, Myśliwiec P, Chabowski A. Does TBC1D4 (AS160) or TBC1D1 Deficiency Affect the Expression of Fatty Acid Handling Proteins in the Adipocytes Differentiated from Human Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Obtained from Subcutaneous and Visceral Fat Depots? Cells 2021;10:1515. [PMID: 34208471 DOI: 10.3390/cells10061515] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Mughal M, Sindali K, Man J, Roblin P. 'Fat chance': a review of adipose tissue engineering and its role in plastic and reconstructive surgery. Ann R Coll Surg Engl 2021;103:245-9. [PMID: 33682428 DOI: 10.1308/rcsann.2020.7031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Liu Q, Chen X, Liu C, Pan L, Kang X, Li Y, Du C, Dong S, Xiang AP, Xu Y, Zhang Q. Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression. Cell Death Dis 2021;12:240. [PMID: 33664231 DOI: 10.1038/s41419-021-03524-y] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
9 Li Y, Lin Y, Han X, Li W, Yan W, Ma Y, Lu X, Huang X, Bai R, Zhang H. GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients. iScience 2021;24:102149. [PMID: 33665568 DOI: 10.1016/j.isci.2021.102149] [Reference Citation Analysis]
10 Alishahi M, Anbiyaiee A, Farzaneh M, Khoshnam SE. Human Mesenchymal Stem Cells for Spinal Cord Injury. Curr Stem Cell Res Ther 2020;15:340-8. [PMID: 32178619 DOI: 10.2174/1574888X15666200316164051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
11 Liao N, Zhang D, Wu M, Yang H, Liu X, Song J. Enhancing therapeutic effects and in vivo tracking of adipose tissue-derived mesenchymal stem cells for liver injury using bioorthogonal click chemistry. Nanoscale 2021;13:1813-22. [PMID: 33433536 DOI: 10.1039/d0nr07272a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Asadi M, Lotfi H, Salehi R, Mehdipour A, Zarghami N, Akbarzadeh A, Alizadeh E. Hepatic cell-sheet fabrication of differentiated mesenchymal stem cells using decellularized extracellular matrix and thermoresponsive polymer. Biomed Pharmacother 2021;134:111096. [PMID: 33338746 DOI: 10.1016/j.biopha.2020.111096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Feng YX, Li W, Wen XD, Zhang N, Liu WH, Yang ZY. Sinusoidal Endothelial Cell Progenitor Cells Promote Tumour Progression in Patients with Hepatocellular Carcinoma. Stem Cells Int 2020;2020:8819523. [PMID: 33312206 DOI: 10.1155/2020/8819523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Philips CA, Augustine P. Still 'dwelling in the possibility' - critical update on stem cell therapy for acute on chronic liver failure. World J Stem Cells 2020; 12(10): 1124-1132 [PMID: 33178396 DOI: 10.4252/wjsc.v12.i10.1124] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhou GP, Jiang YZ, Sun LY, Zhu ZJ. Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther 2020;11:419. [PMID: 32977828 DOI: 10.1186/s13287-020-01935-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hu C, Zhao L, Zhang L, Bao Q, Li L. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Res Ther. 2020;11:377. [PMID: 32883343 DOI: 10.1186/s13287-020-01895-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
17 Heirani-Tabasi A, Mirahmadi M, Mishan MA, Naderi-Meshkin H, Toosi S, Matin MM, Bidkhori HR, Bahrami AR. Comparison the effects of hypoxia-mimicking agents on migration-related signaling pathways in mesenchymal stem cells. Cell Tissue Bank 2020;21:643-53. [PMID: 32815062 DOI: 10.1007/s10561-020-09851-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Liu S, Xu X, Liang S, Chen Z, Zhang Y, Qian A, Hu L. The Application of MSCs-Derived Extracellular Vesicles in Bone Disorders: Novel Cell-Free Therapeutic Strategy. Front Cell Dev Biol 2020;8:619. [PMID: 32793590 DOI: 10.3389/fcell.2020.00619] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
19 Liu Z, Deng Y, Li T, Zhu F, Zhou X, He Y. The opposite functions of miR-24 in the osteogenesis and adipogenesis of adipose-derived mesenchymal stem cells are mediated by the HOXB7/β-catenin complex. FASEB J 2020;34:9034-50. [PMID: 32413244 DOI: 10.1096/fj.202000006RR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Cao Y, Ji C, Lu L. Mesenchymal stem cell therapy for liver fibrosis/cirrhosis. Ann Transl Med 2020;8:562. [PMID: 32775363 DOI: 10.21037/atm.2020.02.119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
21 Xing X, Han S, Cheng G, Ni Y, Li Z, Li Z. Proteomic Analysis of Exosomes from Adipose-Derived Mesenchymal Stem Cells: A Novel Therapeutic Strategy for Tissue Injury. Biomed Res Int 2020;2020:6094562. [PMID: 32190672 DOI: 10.1155/2020/6094562] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
22 Zhang S, Jiang L, Hu H, Wang H, Wang X, Jiang J, Ma Y, Yang J, Hou Y, Xie D, Zhang Q. Pretreatment of exosomes derived from hUCMSCs with TNF-α ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage. Life Sci 2020;246:117401. [PMID: 32035931 DOI: 10.1016/j.lfs.2020.117401] [Cited by in Crossref: 20] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
23 Chu X, Karasinski K, Donellan S, Kaniper S, Wood GC, Shi W, Edwards MA, Soans R, Still CD, Gerhard GS. A retrospective case control study identifies peripheral blood mononuclear cell albumin RNA expression as a biomarker for non-alcoholic fatty liver disease. Langenbecks Arch Surg 2020;405:165-72. [PMID: 31828503 DOI: 10.1007/s00423-019-01848-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Ritter A, Friemel A, Roth S, Kreis NN, Hoock SC, Safdar BK, Fischer K, Möllmann C, Solbach C, Louwen F, Yuan J. Subcutaneous and Visceral Adipose-Derived Mesenchymal Stem Cells: Commonality and Diversity. Cells 2019;8:E1288. [PMID: 31640218 DOI: 10.3390/cells8101288] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]